Maternal Phenylketonuria Collaborative Study (MPKUCS)--the 'outliers'

Area of Science:

• Genetics
• Neuroscience
• Metabolic Disorders

Background:

• Maternal Phenylketonuria (PKU) poses risks to fetal neurodevelopment.
• Adequate metabolic control during pregnancy is crucial for offspring outcomes.
• Previous studies highlight the impact of maternal phenylalanine levels on infant IQ.

Purpose of the Study:

• Investigate intellectual outcome outliers in offspring from the Maternal Phenylketonuria Collaborative Study (MPKUCS).
• Determine if incomplete data or biological variants explain intellectual performance discrepancies.
• Explore the potential role of modifier genes in fetal protection during maternal PKU.

Main Methods:

• Analysis of outcome data from 305 offspring in the MPKUCS and 70 control offspring.
• Assessment of intelligence quotient (IQ) using the Wechsler Intelligence Scale for Children--Revised (WISC-R).
• Identification and investigation of intellectual 'outliers' (better or worse than expected IQ).

Main Results:

• Significant IQ deficits observed in offspring with delayed/inadequate maternal metabolic control.
• Ten offspring showed worse-than-expected IQ, with additional complications identified.
• Thirteen offspring exhibited better-than-expected IQ; four had mothers with mild PKU variants, nine remained unexplained.

Conclusions:

• While poor maternal metabolic control negatively impacts offspring IQ, biological variations exist.
• Modifier genes are hypothesized to protect fetuses from high maternal phenylalanine levels.
• Further research into genetic modifiers could inform PKU treatment strategies.